The use of BM-DCs/T4 + TAg (tumor antigen) resulted in increased expression of differentiation markers and an enhanced ability to stimulate T cells to produce IFN-γ in C57BL/6 mice carrying advanced MC38 colon carcinoma tumors. Here, IFNG is linked to neoplasm.